immatics biotechnologies GmbH (IMTXW)
Upgrades & Downgrades
Latest IMTXW news
Immatics Extends Cell Therapy Manufacturing Collaboration with UTHealth
6 August 2020
Houston, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- * Extension of collaboration between UTHealth and Immatics until end of 2024 providing Immatics exclusive access to state-of-the art cGMP manufactu...
Immatics Announces Board of Directors Additions Following Public Listing on NASDAQ
9 July 2020
Houston, Texas and Tuebingen, Germany, July 09, 2020 -- Houston, Texas and Tuebingen, Germany, July 9, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage.